The Phase III 'High Five Trial' Five Fraction Radiation for High-Risk Prostate Cancer
Details
This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period of time. This trial is evaluating if shorter duration radiation prevents cancer from coming back as well as the usual radiation treatment.
Eligibility
You can join if...
Inclusion Criteria:
Age >= 18
No prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields